Wajd Life Trading Co.
9647XSAUSaudi Exchange·Healthcare
SAR 4.64
▼︎ 1.28%(-0.06)
ClosedLast price May 19
Data as of 19 May 2026
Open
SAR 4.64
High
SAR 4.64
Low
SAR 4.64
Volume
986
52W High
SAR 7.00
52W Low
SAR 4.64
1W
-1.28%
1M
-18.88%
3M
-16.40%
6M
-16.85%
YTD
-17.88%
1Y
—
Mīzān Analysis
19/60
Weak overall profile at current prices
Low Liquidity
9647Sector
Market Cap
71.5M SAR
P/E
—
Revenue Growth
47.3%
Div Yield
—
Rewards
No standout positive signals at current scores.
Risk Analysis
No significant risk flags at current scores.
Scores computed 19 May 2026
Fundamentals
Market Cap
P/E Ratio
P/B Ratio
EPS
EPS Growth
Revenue
Revenue Growth
Net Income
Profit Margin
Debt / Assets
Dividend Yield
Dividend Per Share
Shares Outstanding
Reporting Period: 2023-12-31Data as of Apr 24, 2026
Mizān Summary
News
Sector News10Industry & macro context
UAE Business: MedLab launches new surgical training hub at Dubai Science Park
Gulf Daily News· 6 days agoNeutralEconomy
Trade ministers discuss final steps for GCC-UK FTA
Qatar Tribune· 7 days agoNeutralEconomy
UAE launches global plan to reach 42 million people, eradicate river blindness by 2030
Economy Middle East· 9 days agoNeutral
UAE Business: PureHealth surpasses $1.72bn in local procurement spend
Gulf Daily News· 12 days agoEconomy
Bahrain SWF Mumtalakat, SandboxAQ to boost Bahrain’s biotech sector
MSN· 18 days agoNeutralEconomy
Abu Dhabi’s PureHealth Q1 2026 revenue rises 10 percent to $2 billion on global expansion
Economy Middle East· 19 days agoNeutral
Omani delegation visits China to explore high tech pharmaceutical and medical ventures
Times of Oman· 21 days agoNeutralEconomy
Memo to enhance training, employment in pharmaceutical industry inked
وكالة الانباء الاردنية· 29 days agoNeutralEconomy
Trump nominates Erica Schwartz as CDC director amid turmoil around leadership, vaccine policy
CNBC Business· about 1 month agoNeutralMarket Movers
RFK Jr.'s peptide policy could boost Hims & Hers as its GLP-1 business evolves
CNBC Business· about 1 month agoPositiveMarket Movers
Events
No upcoming corporate events